Regulation of the tumor suppressor PTEN by natural anticancer compounds

被引:49
作者
Kim, Do-Hee [1 ]
Suh, Jinyoung [1 ]
Surh, Young-Joon [1 ,2 ,3 ]
Na, Hye-Kyung [4 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea
[2] Seoul Natl Univ, Grad Sch Convergence Sci, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea
[3] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
[4] Sungshin Womens Univ, Dept Food Sci & Biotechnol, Coll Knowledge Based Serv Engn, 55 Dobong Ro 76ga Gil, Seoul 01133, South Korea
基金
新加坡国家研究基金会;
关键词
PTEN; PI3K; Akt; natural anticancer compounds; ACTIVATED-RECEPTOR-GAMMA; FORKHEAD TRANSCRIPTION FACTORS; SQUAMOUS-CELL CARCINOMA; LUNG-CANCER CELLS; PPAR-GAMMA; PROSTATE-CANCER; UP-REGULATION; REDOX REGULATION; DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA;
D O I
10.1111/nyas.13422
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The tumor suppressor phosphatase and tensin homologue (PTEN) has phosphatase activity, with phosphatidylinositol (3,4,5)-trisphosphate (PIP3), a product of phosphatidylinositol 3-kinase (PI3K), as one of the principal substrates. PTEN is a negative regulator of the Akt pathway, which plays a fundamental role in controlling cell growth, survival, and proliferation. Loss of PTEN function has been observed in many different types of cancer. Functional inactivation of PTEN as a consequence of germ-line mutations or promoter hypermethylation predisposes individuals to malignancies. PTEN undergoes posttranslational modifications, such as oxidation, acetylation, phosphorylation, SUMOylation, and ubiquitination, which influence its catalytic activity, interactions with other proteins, and subcellular localization. Cellular redox status is crucial for posttranslational modification of PTEN and its functional consequences. Oxidative stress and inflammation are major causes of loss of PTEN function. Pharmacologic or nutritional restoration of PTEN function is considered a reliable strategy in the management of PTEN-defective cancer. In this review, we highlight natural compounds, such as curcumin, indol-3 carbinol, and omega-3 fatty acids, that have the potential to restore or potentiate PTEN expression/activity, thereby suppressing cancer cell proliferation, survival, and resistance to chemotherapeutic agents.
引用
收藏
页码:136 / 149
页数:14
相关论文
共 107 条
[1]   RETRACTED: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF (Retracted article. See vol. 78, pg. 5466, 2018) [J].
Ali, Shadan ;
Ahmad, Aamir ;
Banerjee, Sanjeev ;
Padhye, Subhash ;
Dominiak, Kristin ;
Schaffert, Jacqueline M. ;
Wang, Zhiwei ;
Philip, Philip A. ;
Sarkar, Fazlul H. .
CANCER RESEARCH, 2010, 70 (09) :3606-3617
[2]  
[Anonymous], 2010, SCI SIGNAL, DOI DOI 10.1126/SCISIGNAL.2000594
[3]   Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells [J].
Arafa, El-Shaimaa A. ;
Zhu, Qianzheng ;
Shah, Zubair I. ;
Wani, Gulzar ;
Barakat, Bassant M. ;
Racoma, Ira ;
El-Mandy, Mohamed A. ;
Wani, Altar A. .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2011, 706 (1-2) :28-35
[4]   The Antiproliferative Response of Indole-3-Carbinol in Human Melanoma Cells Is Triggered by an Interaction with NEDD4-1 and Disruption of Wild-Type PTEN Degradation [J].
Aronchik, Ida ;
Kundu, Aishwarya ;
Quirit, Jeanne G. ;
Firestone, Gary L. .
MOLECULAR CANCER RESEARCH, 2014, 12 (11) :1621-1634
[5]   Review on Molecular and Therapeutic Potential of Thymoquinone in Cancer [J].
Banerjee, Sanjeev ;
Padhye, Subhash ;
Azmi, Asfar ;
Wang, Zhiwei ;
Philip, Philip A. ;
Kucuk, Omer ;
Sarkar, Fazlul H. ;
Mohammad, Ramzi M. .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2010, 62 (07) :938-946
[6]   Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress [J].
Bassi, C. ;
Ho, J. ;
Srikumar, T. ;
Dowling, R. J. O. ;
Gorrini, C. ;
Miller, S. J. ;
Mak, T. W. ;
Neel, B. G. ;
Raught, B. ;
Stambolic, V. .
SCIENCE, 2013, 341 (6144) :395-399
[7]   Activation of AKT kinases in cancer: Implications for therapeutic targeting [J].
Bellacosa, A ;
Kumar, CC ;
Di Cristofano, A ;
Testa, JR .
ADVANCES IN CANCER RESEARCH, VOL 94, 2005, 94 :29-+
[8]   Modulation of prostate cancer genetic risk by ornega-3 and ornega-6 fatty acids [J].
Berquin, Isabelle M. ;
Min, Younong ;
Wu, Ruping ;
Wu, Jiansheng ;
Perry, Donna ;
Cline, J. Mark ;
Thomas, Mike J. ;
Thornburg, Todd ;
Kulik, George ;
Smith, Adrienne ;
Edwards, Iris J. ;
D'Agostino, Ralph, Jr. ;
Zhang, Hao ;
Wu, Hong ;
Kang, Jing X. ;
Chen, Yong Q. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (07) :1866-1875
[9]   Estrogen receptor α binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor γ signaling in breast cancer cells [J].
Bonofiglio, D ;
Gabriele, S ;
Aquila, S ;
Catalano, S ;
Gentile, M ;
Middea, E ;
Giordano, F ;
Andò, S .
CLINICAL CANCER RESEARCH, 2005, 11 (17) :6139-6147
[10]   Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty [J].
Burgering, BMT ;
Medema, RH .
JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 73 (06) :689-701